Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
108.60    6.60 (6.47%)
Bid:
108.40
Ask:
109.60
Spread: 1.20 (1.107%)
Market Cap: £178.04m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Trading update

11 Jul 2014 07:00

RNS Number : 0240M
Synthomer PLC
11 July 2014
 



11th July 2014

 

Synthomer plc

 

Trading update

 

Synthomer plc ("Synthomer" or the "Group") today issues a trading update ahead of its interim results on 11th August 2014.

 

The Group has continued to see similar trends to those seen during the first quarter of the year which it highlighted at the time of its Interim Management Statement on 1 May 2014.

 

In Europe and North America, trading has continued in line with the first quarter of the year and our expectations. Volumes were ahead of the prior year in our Construction & Coatings, Functional Polymers and Performance Polymers segments, whilst average cash margins in the second quarter have remained similar to the first three months of 2014.

 

In Asia and Rest of the World, the strong competition between glove manufacturers that we reported at the time of our Q1 IMS in May has continued. This has caused ongoing margin pressure in our Nitrile business, exacerbated by weak Butadiene pricing and a related period of customer de-stocking. This prolonged pressure means that operating profit for the first half of the year for Asia will be approximately £4m below our first half performance in 2013 (H1 2013: £11.5m). However, as the second half progresses we continue to expect demand for nitrile latex to grow and unit margins to firm.

 

In addition, sterling strengthened further during the period. As a result, we now expect currency translation to have an adverse impact on full year operating profit of approximately £5m, an increase of £1m over our original expectations, assuming no further change to current rates.

 

The result of weaker margins in our nitrile business and adverse currency translation means that we now expect full year profit before tax to be broadly in-line with the level achieved in 2013.

Enquiries:

 

Adrian Whitfield, Chief Executive OfficerDavid Blackwood, Chief Financial Officer

Tel: 01279 436 211

Pendomer Communications

Charles Armitstead / Rosie Oddy

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.00am (BST) today:

 

Dial-In: +44 203 427 0662.

Please quote "Synthomer" to gain access to the call.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGMNKGKGDZM
Date   Source Headline
29th Sep 20227:00 amRNSTrading update
23rd Sep 20229:23 amRNSHolding(s) in Company
12th Sep 20223:27 pmRNSHolding(s) in Company
6th Sep 20228:15 amRNSHolding(s) in Company
12th Aug 20229:22 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20224:09 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.